At DDL 2024, CHI's Dr Heather Jameson presented a paper that explained a method to enable precise tuning of a multi-stage Dry Powder Inhaler for diverse formulations, by mapping the design space, revealing key parameters that enhance payload delivery.
The paper was co-written with CHI's CEO David Harris, Jacob Harker (BnL Pharma Solutions) and Karina Joyce, Helen Samuel, and Max Allsworth (all Owlstone Medical).